Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G3DM
|
|||
| Drug Name |
Indazolyl-thiadiazolamine derivative 1
|
|||
| Synonyms |
PMID28048944-Compound-8
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
LYCERA CORPORATION
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H18N8O2S
|
|||
| Canonical SMILES |
C1=CC(=CC(=C1)NC(=O)C2=CN(N=C2)CCO)C3=NN=C(S3)NC4=CC5=C(C=C4)NN=C5
|
|||
| InChI |
1S/C21H18N8O2S/c30-7-6-29-12-15(11-23-29)19(31)24-16-3-1-2-13(8-16)20-27-28-21(32-20)25-17-4-5-18-14(9-17)10-22-26-18/h1-5,8-12,30H,6-7H2,(H,22,26)(H,24,31)(H,25,28)
|
|||
| InChIKey |
QFQWUHMXGFJZJO-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rho kinase inhibitors: a patent review (2014 - 2016).Expert Opin Ther Pat. 2017 Apr;27(4):507-515. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.